Ranking · Trials

Sponsor concentration (HHI)

Herfindahl–Hirschman index of lead sponsors over active interventional studies (sum of squared sponsor shares; 1 = a single sponsor). Requires ≥ 10 active studies.

Computedci-sponsor-hhi-v1unit: index (0–1)higher is first (neutral)All metrics

Rank	Δ	Cancer	Sponsor concentration (HHI) (index (0–1))	Percentile	Confidence	Sources	Why #n?
1	=	Kaposi Sarcoma	0.228	100	Medium confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 18 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.3888889 distinctSponsors 8 activeWithSponsor 18 ranking row 2569698
2	=	Malignant Nasopharyngeal Neoplasm	0.135	97.1	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor Sun Yat-sen University aggregation descendants activeTrials 261 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.35249043 distinctSponsors 80 activeWithSponsor 261 ranking row 2569699
3	=	Malignant Hypopharyngeal Neoplasm	0.094	94.3	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 53 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.24528302 distinctSponsors 26 activeWithSponsor 53 ranking row 2569700
4	=	Malignant Laryngeal Neoplasm	0.071	91.4	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 66 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.21212122 distinctSponsors 36 activeWithSponsor 66 ranking row 2569701
5	=	Malignant Gallbladder Neoplasm	0.057	88.6	Medium confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 32 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.15625 distinctSponsors 25 activeWithSponsor 32 ranking row 2569702
6	=	Malignant Vaginal Neoplasm	0.053	85.7	Medium confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 31 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.12903225 distinctSponsors 24 activeWithSponsor 31 ranking row 2569703
7	=	Malignant Penile Neoplasm	0.052	82.9	Medium confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 43 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.13953489 distinctSponsors 28 activeWithSponsor 43 ranking row 2569704
8	=	Malignant Salivary Gland Neoplasm	0.046	80	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 63 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.15873016 distinctSponsors 44 activeWithSponsor 63 ranking row 2569705
9	=	Cutaneous Melanoma	0.039	77.1	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 78 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.15384616 distinctSponsors 55 activeWithSponsor 78 ranking row 2569706
10	=	Malignant Testicular Neoplasm	0.038	74.3	Medium confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor University Health Network, Toronto aggregation descendants activeTrials 43 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.093023255 distinctSponsors 32 activeWithSponsor 43 ranking row 2569707
11	=	Malignant Mesothelioma	0.027	71.4	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 96 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.09375 distinctSponsors 70 activeWithSponsor 96 ranking row 2569708
12	=	Malignant Oropharyngeal Neoplasm	0.026	68.6	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 143 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.10489511 distinctSponsors 86 activeWithSponsor 143 ranking row 2569709
13	=	Malignant Lip and Oral Cavity Neoplasm	0.025	65.7	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 149 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.10738255 distinctSponsors 88 activeWithSponsor 149 ranking row 2569710
14	=	Malignant Vulvar Neoplasm	0.025	62.9	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 54 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.055555556 distinctSponsors 46 activeWithSponsor 54 ranking row 2569711
15	=	Hodgkin Lymphoma	0.023	60	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor City of Hope Medical Center aggregation descendants activeTrials 179 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.0726257 distinctSponsors 97 activeWithSponsor 179 ranking row 2569712
16	=	Malignant Anal Neoplasm	0.023	57.1	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 68 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.0882353 distinctSponsors 58 activeWithSponsor 68 ranking row 2569713
17	=	Skin Carcinoma	0.02	54.3	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 127 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.08661418 distinctSponsors 90 activeWithSponsor 127 ranking row 2569714
18	=	Malignant Thyroid Gland Neoplasm	0.019	51.4	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor M.D. Anderson Cancer Center aggregation descendants activeTrials 176 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.07386363 distinctSponsors 114 activeWithSponsor 176 ranking row 2569715
19	=	Malignant Kidney Neoplasm	0.015	48.6	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor M.D. Anderson Cancer Center aggregation descendants activeTrials 453 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.07064018 distinctSponsors 251 activeWithSponsor 453 ranking row 2569716
20	=	Malignant Bladder Neoplasm	0.013	45.7	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 346 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.07225434 distinctSponsors 205 activeWithSponsor 346 ranking row 2569717
21	=	Leukemia	0.012	42.9	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor M.D. Anderson Cancer Center aggregation descendants activeTrials 1769 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.063312605 distinctSponsors 593 activeWithSponsor 1769 ranking row 2569718
22	=	Multiple Myeloma	0.012	40	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 814 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.05159705 distinctSponsors 325 activeWithSponsor 814 ranking row 2569719
23	=	Malignant Cervical Neoplasm	0.012	37.1	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 505 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.07920792 distinctSponsors 306 activeWithSponsor 505 ranking row 2569720
24	=	Malignant Uterine Corpus Neoplasm	0.011	34.3	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 411 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.06812652 distinctSponsors 257 activeWithSponsor 411 ranking row 2569721
25	=	Malignant Colon Neoplasm	0.011	31.4	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor M.D. Anderson Cancer Center aggregation descendants activeTrials 225 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.035555556 distinctSponsors 156 activeWithSponsor 225 ranking row 2569722
26	=	Malignant Ovarian Neoplasm	0.01	28.6	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 684 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.062865496 distinctSponsors 376 activeWithSponsor 684 ranking row 2569723
27	=	Malignant Rectal Neoplasm	0.01	25.7	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor Fudan University aggregation descendants activeTrials 386 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.04404145 distinctSponsors 219 activeWithSponsor 386 ranking row 2569724
28	=	Non-Hodgkin Lymphoma	0.009	22.9	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 2168 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.050738007 distinctSponsors 691 activeWithSponsor 2168 ranking row 2569725
29	=	Malignant Esophageal Neoplasm	0.008	20	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 518 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.025096525 distinctSponsors 267 activeWithSponsor 518 ranking row 2569726
30	=	Malignant Liver Neoplasm	0.008	17.1	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor Sun Yat-sen University aggregation descendants activeTrials 906 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.04415011 distinctSponsors 416 activeWithSponsor 906 ranking row 2569727
31	=	Malignant Central Nervous System Neoplasm	0.008	14.3	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 823 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.044957474 distinctSponsors 425 activeWithSponsor 823 ranking row 2569728
32	=	Malignant Gastric Neoplasm	0.007	11.4	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor Fudan University aggregation descendants activeTrials 652 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.027607363 distinctSponsors 349 activeWithSponsor 652 ranking row 2569729
33	=	Malignant Breast Neoplasm	0.006	8.6	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor Fudan University aggregation descendants activeTrials 2627 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.036162924 distinctSponsors 961 activeWithSponsor 2627 ranking row 2569730
34	=	Malignant Prostate Neoplasm	0.005	5.7	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor M.D. Anderson Cancer Center aggregation descendants activeTrials 1375 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.026181819 distinctSponsors 580 activeWithSponsor 1375 ranking row 2569731
35	=	Malignant Pancreatic Neoplasm	0.005	2.9	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor National Cancer Institute (NCI) aggregation descendants activeTrials 904 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.028761063 distinctSponsors 503 activeWithSponsor 904 ranking row 2569732
36	=	Malignant Lung Neoplasm	0.004	0	High confidence	clinicaltrials	inputs asOf 2026-09-29 studyType INTERVENTIONAL topSponsor AstraZeneca aggregation descendants activeTrials 2644 activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING formulaVersion ci-trial-intel-v1 minActiveTrials 10 topSponsorShare 0.022314675 distinctSponsors 980 activeWithSponsor 2644 ranking row 2569733

Data updated 17 hours agoSource updated unknown36 eligible entities · inputs hash 83b7eb11d6a8211487fc7df9